NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| INSM | Insmed Inc | Healthcare | Biotechnology | 1.96% |
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 1.88% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.76% |
| EXAS | EXACT Sciences Corporation | Healthcare | Diagnostics & Research | 1.74% |
| NBIX | Neurocrine Biosciences Inc | Healthcare | Drug Manufacturers - Specialty & Generic | 1.71% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 1.70% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 1.53% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.47% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.42% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 1.41% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.39% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 1.39% |
| ABBV | AbbVie Inc | Healthcare | Drug Manufacturers - General | 1.36% |
| EXEL | Exelixis Inc | Healthcare | Biotechnology | 1.33% |
| MDGL | Madrigal Pharmaceuticals Inc | Healthcare | Biotechnology | 1.23% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.17% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 1.13% |
| BBIO | BridgeBio Pharma Inc | Healthcare | Biotechnology | 1.11% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 1.04% |